Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biomarin Pharmaceutical Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BMRN
Nasdaq
2834
https://www.biomarin.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biomarin Pharmaceutical Inc
Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?
- Mar 28th, 2024 3:30 pm
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
- Mar 16th, 2024 9:06 am
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
- Mar 12th, 2024 12:30 pm
BioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
- Mar 11th, 2024 2:00 pm
Insider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...
- Mar 8th, 2024 6:31 am
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
- Mar 7th, 2024 1:30 pm
BioMarin Scheduled to Participate in March Investor Conferences
- Mar 1st, 2024 2:00 pm
Decoding Biomarin Pharmaceutical Inc (BMRN): A Strategic SWOT Insight
- Feb 27th, 2024 5:03 am
REFILE-UPDATE 2-BioMarin Pharma gets DOJ subpoena on sponsored testing programs for two therapies
- Feb 26th, 2024 7:36 pm
BioMarin Pharmaceutical Full Year 2023 Earnings: EPS: US$0.89 (vs US$0.76 in FY 2022)
- Feb 24th, 2024 1:33 pm
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 5:33 pm
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
- Feb 23rd, 2024 4:34 pm
Q4 2023 Biomarin Pharmaceutical Inc Earnings Call
- Feb 23rd, 2024 12:21 pm
20 Fastest Growing Biotech Companies in the US
- Feb 23rd, 2024 10:43 am
BioMarin preaches patience amid slow sales for hemophilia gene therapy
- Feb 23rd, 2024 9:25 am
Here's What Key Metrics Tell Us About BioMarin (BMRN) Q4 Earnings
- Feb 22nd, 2024 11:00 pm
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
- Feb 22nd, 2024 10:15 pm
BioMarin Pharmaceutical Inc. (BMRN) Announces Record Financial Results for 2023
- Feb 22nd, 2024 9:42 pm
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
- Feb 22nd, 2024 9:03 pm
5 Stocks Likely to Gain on Q4 Earnings Today After Market Close
- Feb 22nd, 2024 12:10 pm
Scroll